Project Grant R01AA031460
Award Date
9/20/24
Completion Date
6/30/29
Dollars Obligated
$538K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This $442,898 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research to define the contributions of macrophage migration inhibitory factor (MIF) and its receptor CD74 in alcohol-associated liver disease (ALD). The research plan includes three specific aims: 1) characterizing the role of CD74 expression in hepatocytes and myeloid cells during and after ethanol feeding in mice, 2) resolving the...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will provide $119,600 over a 3-year period from July 2024 to July 2027 to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to conduct research on the mechanisms by which aging and alcohol consumption cooperatively contribute to the development of alcohol-associated liver disease (ALD). The project aims to identify how...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $438,375 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Cedars-Sinai Medical Center to establish a human liver-on-a-chip model for studying alcohol-associated liver disease (ALD). The 2-year project, starting September 2023, aims to investigate the roles of liver sinusoidal endothelial cells and acetaldehyde metabolism in regulating ethanol-induced liver damage as well as the contribution of fibrotic...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports research to investigate the role of histone demethylases KDM5B and KDM5C in alcohol-associated liver disease (ALD) development and resolution. The $1,547,718 award to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) aims to: 1) Determine the impact of KDM5 demethylases on cellular crosstalk in ALD,...
This federal Project Grant award, valued at $523,477.00 and awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) on September 25, 2024, supports research to study alcohol-associated liver disease (ALD) and its interaction with the rs738409 variant in the PNPLA3 gene. The key products and services to be delivered under this grant include: Developing a human induced pluripotent stem cell (hiPSC)-derived in vitro liver culture...
This federal Project Grant award of $380,863 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), supports research on the role of specific hepatic stellate cell subsets in the progression of alcohol-associated hepatitis (AH). The project aims to determine how the genes CYP1B1, PRRX1, and NR4A2 regulate the development and function of a novel FBLN2+ activated hepatic stellate cell (AHSC) subset in AH. Planned activities include...
This $1,158,934 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports research to understand the mechanisms of mitochondrial dysfunction, quality control, and mitochondrial DNA-mediated inflammation in alcohol-associated liver disease. The key objectives are to investigate how chronically accumulated "megamitochondria" resulting from alcohol exposure impair...
This federal Project Grant award, ID R21AA031563, was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award, totaling $374,598.00 and effective from August 15, 2024 to July 31, 2026, will support research investigating the impact of alcohol consumption on RNA chemical modifications and their contribution to the development and progression of alcohol-associated liver disease (ALD). The research...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, provides $688,199 to Yale University from June 2025 to February 2030. The project aims to examine the role of human non-parenchymal cells (NPCs) in driving the key features of alcohol-associated hepatitis (AAH) in a fully humanized mouse liver model. The research will investigate specific NPC-derived ligands and their...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support research to determine the role of the TET1 enzyme and sex differences in alcohol-associated liver disease (ALD) and hepatocellular carcinoma (HCC) development. The $477,626 award, spanning May 2025 to April 2030, will be provided to Tulane University to conduct in vivo studies investigating the impact of female sex and...